NEA 18 Venture Growth Equity L.P. 13D/13G Filings for Zenas BioPharma, Inc. (ZBIO)

NEA 18 Venture Growth Equity L.P. 13D and 13G filings for Zenas BioPharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-09-25
6:00 pm
Purchase		 2024-09-16 13G Zenas BioPharma, Inc.
ZBIO		 NEA 18 Venture Growth Equity L.P. 2,613,948
6.600%		 2,613,948increase
(New Position)		 Filing